Krsnaa Diagnostics Limited · NSE:KRSNAA
Krsnaa Diagnostics — Q1 FY2025 Earnings Presentation
15 slides from Krsnaa Diagnostics's earnings presentation, Aug 7, 2024
Slide 1: Regulation 30 intimation: revised investor presentation
Date: August 07, 2024 Ref. No.: KDL/SE/057/2024-25 To, To, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, Plot No. C-1, Block G, 25th Floor, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (East) Dalal Street, Mumbai- 400001 Mumbai – 400
Slide 2: Q1FY2025 Result Presentation
Q1FY2025 Result Presentation One of INDIA’S LARGEST Differentiated Diagnostic Service Provider August 2024
Slide 3: Q1FY2025 Performance
@® Q1FY2025 Performance
Slide 4: Krsnaa Diagnostics Operations at a Glance
Krsnaa Diagnostics Krsnaa Operations- Diagnostics Q1FY25At – aOperations Glance at a Glance Radiology Pathology India's 1st India’s 1st CAP Accreditation NABH Accredited Tele 168 120 in Govt. Hospital radiology HUB CT/MRI Centres Processing lab 1,443 NABH NABL 2,270 Tele-Reporting Collection Centre
Slide 5: Financials at a Glance
Krsnaa Diagnostics Krsnaa Financial- Diagnostics Q1FY25 At a– Glance Financials at a Glance In mn Maintaining Growth Momentum: Achieving 22% YoY Revenue Growth, 39% YoY EBITDA Strengthening & 22% YoY improvement in PAT, on account of network expansion and enhanced operational efficiency Revenue from
Slide 6: Q1FY25 EBITDA Analysis
Q1FY25 EBITDA Analysis EBITDA Margins Before CSR and ESOP In mn Segment Mix Existing Centre New Centre 26% 795 23% c 907 94 348 Q1FY25 Q1FY24 Revenue EBIDTA c Note: Considering the nature of business, financial performance is best evaluated on an annualized basis. 3
Slide 7: Financial Performance
Financial Performance Financial Performance In mn Particulars Q1 FY 25 Q1 FY 24 Q4 FY 24 FY 24 FY 23 Amount % Amount % Amount % Amount % Amount % Revenue from operations 1,702 1,396 1,663 6,196 4,871 Expenses Cost of Material Consumed 429 25% 278 20% 430 26% 1,410 23% 742 15% Employee benefits expen
Slide 8: Operational Highlights
@® Operational Highlights
Slide 9: Pan India Presence in Both Radiology and Pathology
Only OnlyCompany with Company with Pan Pan India India Presence Presence inRadiology in Both Both Radiology and Pathology and Pathology Well Diversified Regional Revenue Mix 11% 28% Q1FY2025 38% 23% West South North East High Headroom to Grow Highest penetration across districts with presence in 1
Slide 10: Recent Developments
@® Recent Developments
Slide 11: PPP Project Implementation on Track
PPP Project Project Implementation under on Track Implementation Radiology Centres Under Implementation Pathology Centres Under Implementation Total Centres Operational Under Total Centres Operational Under CONCEPT B CONCEPT B Implementation Implementation Uttar Pradesh 8 5 3 Delhi 1 1 - DMC 1 - 1 D
Slide 12: Way Forward
@® Way Forward
Slide 13: Growth Strategy
Growth Strategy Growth Strategy We aim to sustain the upward trajectory of our Revenue and PAT CAGR by utilizing our existing facilities and seizing opportunities in untapped markets Tap the growing and Continue to enhance Building the Retail Digital marketing and Enhanced centre underpenetrated our
Slide 14: Krsnaa Diagnostics Edge
Krsnaa Diagnostics Krsnaa Edge Diagnostics Edge ₹ Extensive Strong Scalable & Agile Cost Stakeholder Geographic Brand Equity Business Model Leadership Value Footprint Creation Centres across India with Well positioned to PPP is an asset light Ability to maintain cost Defined strategy to presence in
Slide 15: Contact Information
Contact ContactInformation Information This presentation contains statements that are “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Krsnaa Diagnostics’ future business developments